Filing Flows › Newmont (NEM) › Q3 2026 › vs Q2 2026
Newmont (NEM) Q3 2026 vs Q2 2026 (quarter over quarter)
Newmont's revenue rose $245M (+4%) from $6.1B in Q2 2026 to $6.4B in Q3 2026. The biggest changes: Sales from Concentrate and Other Production +$395M (+21%); Gold Sales from Doré Production −$150M (-4%). Operating margin 49.7% against 50.6% (-0.9 pts).
Newmont, Q3 2026: revenue $6.4B (+15% year over year), operating margin 49.7%, net earnings $2.5B, operating cash flow $2.8B. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Operating margin | 49.7% | 50.6% | -0.9 pts |
| Net margin | 38.9% | 36.0% | +2.9 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Gold Sales from Doré Production | $4.1B | $4.3B | −$150M | -4% |
| Sales from Concentrate and Other Production | $2.2B | $1.8B | $395M | +21% |
| Revenue | $6.4B | $6.1B | $245M | +4% |
| Other income, net | $190M | $107M | $83.0M | +78% |
| Operating profit | $3.2B | $3.1B | $67.0M | +2% |
| Costs & expenses | $3.2B | $3.0B | $178M | +6% |
| Pre-tax earnings | $3.4B | $3.2B | $150M | +5% |
| Cost of revenue | $2.1B | $2.1B | $55.0M | +3% |
| Research & development | $58.0M | $47.0M | $11.0M | +23% |
| General & admin | $82.0M | $74.0M | $8.0M | +11% |
| Other operating costs | $917M | $813M | $104M | +13% |
| Net earnings | $2.5B | $2.2B | $273M | +12% |
| Minority interests | $39.0M | $49.0M | −$10.0M | -20% |
| Income tax | $839M | $952M | −$113M | -12% |
| Depreciation & amortization | $632M | $604M | $28.0M | +5% |
| Working capital & other | $339M | −$118M | $457M | — |
| Operating cash flow | $2.8B | $2.9B | −$156M | -5% |
Questions
How much did Newmont's revenue grow quarter over quarter in Q3 2026?
Newmont's revenue rose $245M (+4%) from $6.1B in Q2 2026 to $6.4B in Q3 2026.
What drove Newmont's revenue change in Q3 2026?
Sales from Concentrate and Other Production +$395M (+21%); Gold Sales from Doré Production −$150M (-4%).